Contemporary Use of Laboratory Tests to Monitor Safety and Efficacy of Thrombolytic Therapy

Hirsch, Denise R.; Goldhaber, Samuel Z.

doi:10.1378/chest.101.4_supplement.98s

Cited by 2 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Systemic thrombolytic activity may be marked by low fibrinogen (<100 mg/dL) or elevated d-dimer. However, thrombolytics' ability to prognosticate a bleeding diathesis has not been established, and in myocardial infarction studies have not correlated with hemorrhagic complications [12].…”

Section: Thrombolysismentioning

confidence: 99%

Intensive care management of ischemic stroke

Nguyen

Koroshetz

2003

Curr Neurol Neurosci Rep

View full text Add to dashboard Cite

The practice of neurointensive care was initially developed to manage postoperative neurosurgical patients and expanded thereafter to the management of patients with primary head trauma, intracranial hemorrhage, vasospasm after subarachnoid hemorrhage, elevated intracranial pressure, and unstable pulmonary or cardiovascular medical conditions in neurologic patients. Can neurointensive care with its advanced medical and neurologic resources improve the outcome of the ischemic stroke patient? This review discusses selection of patients appropriate for admission to the neurologic intensive care unit (NICU) and current options for the intensive care management of severe ischemic stroke and its attendant complications. We propose that the NICU team is well suited to acute stroke management if they apply their advanced skills and technologic resources to manage the severe stroke patient from the time of presentation to the emergency ward. Study is needed to determine the effect that a critical care level of service has on functional outcome.

show abstract

Section: Thrombolysismentioning

confidence: 99%